nodes	percent_of_prediction	percent_of_DWPC	metapath
Dofetilide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.148	0.463	CbGbCtD
Dofetilide—CYP3A4—Progesterone—uterine cancer	0.0979	0.306	CbGbCtD
Dofetilide—CYP3A4—Etoposide—uterine cancer	0.0438	0.137	CbGbCtD
Dofetilide—Infarction—Medroxyprogesterone Acetate—uterine cancer	0.0368	0.0547	CcSEcCtD
Dofetilide—Facial paralysis—Medroxyprogesterone Acetate—uterine cancer	0.0322	0.0477	CcSEcCtD
Dofetilide—CYP3A4—Doxorubicin—uterine cancer	0.0299	0.0935	CbGbCtD
Dofetilide—VIIth nerve paralysis—Medroxyprogesterone Acetate—uterine cancer	0.0249	0.037	CcSEcCtD
Dofetilide—Cerebral ischaemia—Medroxyprogesterone Acetate—uterine cancer	0.0212	0.0314	CcSEcCtD
Dofetilide—Supraventricular tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0156	0.0232	CcSEcCtD
Dofetilide—Paralysis—Medroxyprogesterone Acetate—uterine cancer	0.0147	0.0218	CcSEcCtD
Dofetilide—Accidental injury—Progesterone—uterine cancer	0.0128	0.0189	CcSEcCtD
Dofetilide—Hepatocellular injury—Progesterone—uterine cancer	0.0113	0.0168	CcSEcCtD
Dofetilide—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.0102	0.0152	CcSEcCtD
Dofetilide—Injury—Progesterone—uterine cancer	0.00891	0.0132	CcSEcCtD
Dofetilide—Migraine—Progesterone—uterine cancer	0.00806	0.012	CcSEcCtD
Dofetilide—Cerebrovascular accident—Medroxyprogesterone Acetate—uterine cancer	0.00758	0.0112	CcSEcCtD
Dofetilide—Migraine—Medroxyprogesterone Acetate—uterine cancer	0.00731	0.0108	CcSEcCtD
Dofetilide—Angina pectoris—Progesterone—uterine cancer	0.0069	0.0102	CcSEcCtD
Dofetilide—Pain—Carboplatin—uterine cancer	0.00656	0.00973	CcSEcCtD
Dofetilide—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.00642	0.00952	CcSEcCtD
Dofetilide—Bundle branch block—Epirubicin—uterine cancer	0.00641	0.00952	CcSEcCtD
Dofetilide—Urinary tract infection—Progesterone—uterine cancer	0.00614	0.00911	CcSEcCtD
Dofetilide—Bundle branch block—Doxorubicin—uterine cancer	0.00593	0.00881	CcSEcCtD
Dofetilide—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00564	0.00837	CcSEcCtD
Dofetilide—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00561	0.00832	CcSEcCtD
Dofetilide—Oedema peripheral—Progesterone—uterine cancer	0.00558	0.00829	CcSEcCtD
Dofetilide—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00556	0.00825	CcSEcCtD
Dofetilide—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00549	0.00814	CcSEcCtD
Dofetilide—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00523	0.00776	CcSEcCtD
Dofetilide—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00506	0.00751	CcSEcCtD
Dofetilide—Back pain—Progesterone—uterine cancer	0.00477	0.00708	CcSEcCtD
Dofetilide—Paralysis—Epirubicin—uterine cancer	0.00466	0.00691	CcSEcCtD
Dofetilide—Angioedema—Progesterone—uterine cancer	0.00451	0.00669	CcSEcCtD
Dofetilide—Syncope—Progesterone—uterine cancer	0.00442	0.00657	CcSEcCtD
Dofetilide—Ventricular arrhythmia—Epirubicin—uterine cancer	0.00437	0.00649	CcSEcCtD
Dofetilide—Palpitations—Progesterone—uterine cancer	0.00436	0.00647	CcSEcCtD
Dofetilide—Loss of consciousness—Progesterone—uterine cancer	0.00434	0.00644	CcSEcCtD
Dofetilide—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00432	0.00642	CcSEcCtD
Dofetilide—Paralysis—Doxorubicin—uterine cancer	0.00431	0.0064	CcSEcCtD
Dofetilide—Cough—Progesterone—uterine cancer	0.00431	0.00639	CcSEcCtD
Dofetilide—Cardiac failure—Etoposide—uterine cancer	0.00429	0.00637	CcSEcCtD
Dofetilide—Hypertension—Progesterone—uterine cancer	0.00426	0.00632	CcSEcCtD
Dofetilide—Arthralgia—Progesterone—uterine cancer	0.0042	0.00623	CcSEcCtD
Dofetilide—Chest pain—Progesterone—uterine cancer	0.0042	0.00623	CcSEcCtD
Dofetilide—Anxiety—Progesterone—uterine cancer	0.00419	0.00621	CcSEcCtD
Dofetilide—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00409	0.00606	CcSEcCtD
Dofetilide—Ventricular arrhythmia—Doxorubicin—uterine cancer	0.00405	0.006	CcSEcCtD
Dofetilide—Oedema—Progesterone—uterine cancer	0.00403	0.00598	CcSEcCtD
Dofetilide—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00401	0.00595	CcSEcCtD
Dofetilide—Cardiac arrest—Etoposide—uterine cancer	0.00399	0.00591	CcSEcCtD
Dofetilide—Shock—Progesterone—uterine cancer	0.00396	0.00588	CcSEcCtD
Dofetilide—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00395	0.00586	CcSEcCtD
Dofetilide—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00393	0.00583	CcSEcCtD
Dofetilide—Hyperhidrosis—Progesterone—uterine cancer	0.00389	0.00578	CcSEcCtD
Dofetilide—Liver injury—Epirubicin—uterine cancer	0.00385	0.00571	CcSEcCtD
Dofetilide—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00381	0.00565	CcSEcCtD
Dofetilide—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00381	0.00565	CcSEcCtD
Dofetilide—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00379	0.00563	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00367	0.00544	CcSEcCtD
Dofetilide—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00365	0.00542	CcSEcCtD
Dofetilide—Insomnia—Progesterone—uterine cancer	0.00364	0.00541	CcSEcCtD
Dofetilide—Paraesthesia—Progesterone—uterine cancer	0.00362	0.00537	CcSEcCtD
Dofetilide—Dyspnoea—Progesterone—uterine cancer	0.00359	0.00533	CcSEcCtD
Dofetilide—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00359	0.00533	CcSEcCtD
Dofetilide—Liver injury—Doxorubicin—uterine cancer	0.00356	0.00528	CcSEcCtD
Dofetilide—Cough increased—Epirubicin—uterine cancer	0.00354	0.00525	CcSEcCtD
Dofetilide—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00353	0.00524	CcSEcCtD
Dofetilide—Pain—Progesterone—uterine cancer	0.00344	0.00511	CcSEcCtD
Dofetilide—Atrioventricular block—Epirubicin—uterine cancer	0.00334	0.00495	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00332	0.00493	CcSEcCtD
Dofetilide—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.0033	0.0049	CcSEcCtD
Dofetilide—Gastrointestinal pain—Progesterone—uterine cancer	0.00329	0.00489	CcSEcCtD
Dofetilide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00328	0.00486	CcSEcCtD
Dofetilide—Cough increased—Doxorubicin—uterine cancer	0.00327	0.00485	CcSEcCtD
Dofetilide—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00325	0.00483	CcSEcCtD
Dofetilide—Hepatocellular injury—Epirubicin—uterine cancer	0.00324	0.0048	CcSEcCtD
Dofetilide—Ventricular tachycardia—Epirubicin—uterine cancer	0.00324	0.0048	CcSEcCtD
Dofetilide—Acute coronary syndrome—Etoposide—uterine cancer	0.00318	0.00473	CcSEcCtD
Dofetilide—Abdominal pain—Progesterone—uterine cancer	0.00318	0.00472	CcSEcCtD
Dofetilide—Myocardial infarction—Etoposide—uterine cancer	0.00317	0.0047	CcSEcCtD
Dofetilide—Atrioventricular block—Doxorubicin—uterine cancer	0.00309	0.00458	CcSEcCtD
Dofetilide—Hepatocellular injury—Doxorubicin—uterine cancer	0.00299	0.00444	CcSEcCtD
Dofetilide—Ventricular tachycardia—Doxorubicin—uterine cancer	0.00299	0.00444	CcSEcCtD
Dofetilide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00298	0.00443	CcSEcCtD
Dofetilide—Asthenia—Progesterone—uterine cancer	0.00289	0.00429	CcSEcCtD
Dofetilide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00288	0.00428	CcSEcCtD
Dofetilide—Oedema—Dactinomycin—uterine cancer	0.00285	0.00422	CcSEcCtD
Dofetilide—Diarrhoea—Progesterone—uterine cancer	0.00276	0.00409	CcSEcCtD
Dofetilide—Dizziness—Progesterone—uterine cancer	0.00266	0.00395	CcSEcCtD
Dofetilide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00262	0.00389	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00259	0.00385	CcSEcCtD
Dofetilide—Rash—Progesterone—uterine cancer	0.00254	0.00377	CcSEcCtD
Dofetilide—Dermatitis—Progesterone—uterine cancer	0.00254	0.00376	CcSEcCtD
Dofetilide—Headache—Progesterone—uterine cancer	0.00252	0.00374	CcSEcCtD
Dofetilide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0025	0.00371	CcSEcCtD
Dofetilide—Back pain—Etoposide—uterine cancer	0.00244	0.00362	CcSEcCtD
Dofetilide—Pain—Dactinomycin—uterine cancer	0.00243	0.00361	CcSEcCtD
Dofetilide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.00358	CcSEcCtD
Dofetilide—Cardiac failure—Epirubicin—uterine cancer	0.00241	0.00357	CcSEcCtD
Dofetilide—Cerebrovascular accident—Epirubicin—uterine cancer	0.0024	0.00356	CcSEcCtD
Dofetilide—Nausea—Progesterone—uterine cancer	0.00239	0.00355	CcSEcCtD
Dofetilide—KCNJ12—Inwardly rectifying K+ channels—ABCC9—uterine cancer	0.00233	0.342	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00233	0.00345	CcSEcCtD
Dofetilide—Migraine—Epirubicin—uterine cancer	0.00231	0.00343	CcSEcCtD
Dofetilide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0023	0.00341	CcSEcCtD
Dofetilide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0023	0.00341	CcSEcCtD
Dofetilide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00229	0.00339	CcSEcCtD
Dofetilide—Abdominal pain—Dactinomycin—uterine cancer	0.00225	0.00334	CcSEcCtD
Dofetilide—Cardiac arrest—Epirubicin—uterine cancer	0.00223	0.00332	CcSEcCtD
Dofetilide—Cardiac failure—Doxorubicin—uterine cancer	0.00223	0.00331	CcSEcCtD
Dofetilide—Loss of consciousness—Etoposide—uterine cancer	0.00222	0.00329	CcSEcCtD
Dofetilide—Cerebrovascular accident—Doxorubicin—uterine cancer	0.00222	0.00329	CcSEcCtD
Dofetilide—Cough—Etoposide—uterine cancer	0.0022	0.00327	CcSEcCtD
Dofetilide—Hypertension—Etoposide—uterine cancer	0.00218	0.00323	CcSEcCtD
Dofetilide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00217	0.00322	CcSEcCtD
Dofetilide—Chest pain—Etoposide—uterine cancer	0.00215	0.00319	CcSEcCtD
Dofetilide—Migraine—Doxorubicin—uterine cancer	0.00214	0.00318	CcSEcCtD
Dofetilide—Cardiac arrest—Doxorubicin—uterine cancer	0.00207	0.00307	CcSEcCtD
Dofetilide—Asthenia—Dactinomycin—uterine cancer	0.00204	0.00303	CcSEcCtD
Dofetilide—Influenza—Epirubicin—uterine cancer	0.00203	0.00301	CcSEcCtD
Dofetilide—Hyperhidrosis—Etoposide—uterine cancer	0.00199	0.00296	CcSEcCtD
Dofetilide—Angina pectoris—Epirubicin—uterine cancer	0.00198	0.00294	CcSEcCtD
Dofetilide—Diarrhoea—Dactinomycin—uterine cancer	0.00195	0.00289	CcSEcCtD
Dofetilide—Influenza—Doxorubicin—uterine cancer	0.00188	0.00279	CcSEcCtD
Dofetilide—Paraesthesia—Etoposide—uterine cancer	0.00185	0.00275	CcSEcCtD
Dofetilide—Dyspnoea—Etoposide—uterine cancer	0.00184	0.00273	CcSEcCtD
Dofetilide—Angina pectoris—Doxorubicin—uterine cancer	0.00183	0.00272	CcSEcCtD
Dofetilide—Rash—Dactinomycin—uterine cancer	0.00179	0.00266	CcSEcCtD
Dofetilide—Pain—Etoposide—uterine cancer	0.00176	0.00261	CcSEcCtD
Dofetilide—Urinary tract infection—Epirubicin—uterine cancer	0.00176	0.00261	CcSEcCtD
Dofetilide—Sweating—Epirubicin—uterine cancer	0.00174	0.00258	CcSEcCtD
Dofetilide—Nausea—Dactinomycin—uterine cancer	0.00169	0.00251	CcSEcCtD
Dofetilide—Gastrointestinal pain—Etoposide—uterine cancer	0.00168	0.0025	CcSEcCtD
Dofetilide—Bradycardia—Epirubicin—uterine cancer	0.00165	0.00246	CcSEcCtD
Dofetilide—Abdominal pain—Etoposide—uterine cancer	0.00163	0.00242	CcSEcCtD
Dofetilide—Urinary tract infection—Doxorubicin—uterine cancer	0.00163	0.00242	CcSEcCtD
Dofetilide—Sweating—Doxorubicin—uterine cancer	0.00161	0.00238	CcSEcCtD
Dofetilide—Oedema peripheral—Epirubicin—uterine cancer	0.0016	0.00238	CcSEcCtD
Dofetilide—Bradycardia—Doxorubicin—uterine cancer	0.00153	0.00227	CcSEcCtD
Dofetilide—Oedema peripheral—Doxorubicin—uterine cancer	0.00148	0.0022	CcSEcCtD
Dofetilide—Asthenia—Etoposide—uterine cancer	0.00148	0.00219	CcSEcCtD
Dofetilide—Arrhythmia—Epirubicin—uterine cancer	0.00145	0.00215	CcSEcCtD
Dofetilide—Diarrhoea—Etoposide—uterine cancer	0.00141	0.00209	CcSEcCtD
Dofetilide—Back pain—Epirubicin—uterine cancer	0.00137	0.00203	CcSEcCtD
Dofetilide—Dizziness—Etoposide—uterine cancer	0.00136	0.00202	CcSEcCtD
Dofetilide—Arrhythmia—Doxorubicin—uterine cancer	0.00134	0.00199	CcSEcCtD
Dofetilide—Rash—Etoposide—uterine cancer	0.0013	0.00193	CcSEcCtD
Dofetilide—Dermatitis—Etoposide—uterine cancer	0.0013	0.00193	CcSEcCtD
Dofetilide—Headache—Etoposide—uterine cancer	0.00129	0.00192	CcSEcCtD
Dofetilide—Syncope—Epirubicin—uterine cancer	0.00127	0.00188	CcSEcCtD
Dofetilide—Back pain—Doxorubicin—uterine cancer	0.00127	0.00188	CcSEcCtD
Dofetilide—Palpitations—Epirubicin—uterine cancer	0.00125	0.00186	CcSEcCtD
Dofetilide—Loss of consciousness—Epirubicin—uterine cancer	0.00124	0.00185	CcSEcCtD
Dofetilide—Cough—Epirubicin—uterine cancer	0.00123	0.00183	CcSEcCtD
Dofetilide—Nausea—Etoposide—uterine cancer	0.00122	0.00182	CcSEcCtD
Dofetilide—Hypertension—Epirubicin—uterine cancer	0.00122	0.00181	CcSEcCtD
Dofetilide—Chest pain—Epirubicin—uterine cancer	0.0012	0.00179	CcSEcCtD
Dofetilide—Arthralgia—Epirubicin—uterine cancer	0.0012	0.00179	CcSEcCtD
Dofetilide—Anxiety—Epirubicin—uterine cancer	0.0012	0.00178	CcSEcCtD
Dofetilide—Syncope—Doxorubicin—uterine cancer	0.00117	0.00174	CcSEcCtD
Dofetilide—Palpitations—Doxorubicin—uterine cancer	0.00116	0.00172	CcSEcCtD
Dofetilide—Oedema—Epirubicin—uterine cancer	0.00115	0.00171	CcSEcCtD
Dofetilide—Loss of consciousness—Doxorubicin—uterine cancer	0.00115	0.00171	CcSEcCtD
Dofetilide—Cough—Doxorubicin—uterine cancer	0.00114	0.0017	CcSEcCtD
Dofetilide—Shock—Epirubicin—uterine cancer	0.00114	0.00169	CcSEcCtD
Dofetilide—Hypertension—Doxorubicin—uterine cancer	0.00113	0.00168	CcSEcCtD
Dofetilide—Hyperhidrosis—Epirubicin—uterine cancer	0.00112	0.00166	CcSEcCtD
Dofetilide—Arthralgia—Doxorubicin—uterine cancer	0.00111	0.00165	CcSEcCtD
Dofetilide—Chest pain—Doxorubicin—uterine cancer	0.00111	0.00165	CcSEcCtD
Dofetilide—Anxiety—Doxorubicin—uterine cancer	0.00111	0.00165	CcSEcCtD
Dofetilide—Oedema—Doxorubicin—uterine cancer	0.00107	0.00159	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00105	0.00156	CcSEcCtD
Dofetilide—Shock—Doxorubicin—uterine cancer	0.00105	0.00156	CcSEcCtD
Dofetilide—Insomnia—Epirubicin—uterine cancer	0.00104	0.00155	CcSEcCtD
Dofetilide—Paraesthesia—Epirubicin—uterine cancer	0.00104	0.00154	CcSEcCtD
Dofetilide—Hyperhidrosis—Doxorubicin—uterine cancer	0.00103	0.00153	CcSEcCtD
Dofetilide—Dyspnoea—Epirubicin—uterine cancer	0.00103	0.00153	CcSEcCtD
Dofetilide—Pain—Epirubicin—uterine cancer	0.000987	0.00147	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000973	0.00144	CcSEcCtD
Dofetilide—Insomnia—Doxorubicin—uterine cancer	0.000966	0.00143	CcSEcCtD
Dofetilide—Paraesthesia—Doxorubicin—uterine cancer	0.000959	0.00142	CcSEcCtD
Dofetilide—Dyspnoea—Doxorubicin—uterine cancer	0.000953	0.00141	CcSEcCtD
Dofetilide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000944	0.0014	CcSEcCtD
Dofetilide—KCNJ12—Potassium Channels—ABCC9—uterine cancer	0.000921	0.135	CbGpPWpGaD
Dofetilide—Pain—Doxorubicin—uterine cancer	0.000914	0.00136	CcSEcCtD
Dofetilide—Abdominal pain—Epirubicin—uterine cancer	0.000913	0.00135	CcSEcCtD
Dofetilide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000874	0.0013	CcSEcCtD
Dofetilide—Abdominal pain—Doxorubicin—uterine cancer	0.000845	0.00125	CcSEcCtD
Dofetilide—Asthenia—Epirubicin—uterine cancer	0.000829	0.00123	CcSEcCtD
Dofetilide—Diarrhoea—Epirubicin—uterine cancer	0.00079	0.00117	CcSEcCtD
Dofetilide—Asthenia—Doxorubicin—uterine cancer	0.000767	0.00114	CcSEcCtD
Dofetilide—Dizziness—Epirubicin—uterine cancer	0.000764	0.00113	CcSEcCtD
Dofetilide—Diarrhoea—Doxorubicin—uterine cancer	0.000731	0.00108	CcSEcCtD
Dofetilide—Rash—Epirubicin—uterine cancer	0.000728	0.00108	CcSEcCtD
Dofetilide—Dermatitis—Epirubicin—uterine cancer	0.000727	0.00108	CcSEcCtD
Dofetilide—Headache—Epirubicin—uterine cancer	0.000723	0.00107	CcSEcCtD
Dofetilide—Dizziness—Doxorubicin—uterine cancer	0.000707	0.00105	CcSEcCtD
Dofetilide—Nausea—Epirubicin—uterine cancer	0.000686	0.00102	CcSEcCtD
Dofetilide—Rash—Doxorubicin—uterine cancer	0.000674	0.001	CcSEcCtD
Dofetilide—Dermatitis—Doxorubicin—uterine cancer	0.000673	0.000999	CcSEcCtD
Dofetilide—Headache—Doxorubicin—uterine cancer	0.000669	0.000993	CcSEcCtD
Dofetilide—Nausea—Doxorubicin—uterine cancer	0.000635	0.000942	CcSEcCtD
Dofetilide—KCNK2—Potassium Channels—ABCC9—uterine cancer	0.000585	0.0858	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—uterine cancer	0.000441	0.0647	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—ABCC9—uterine cancer	0.000402	0.0589	CbGpPWpGaD
Dofetilide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.00026	0.0381	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—ABCC9—uterine cancer	0.000255	0.0374	CbGpPWpGaD
Dofetilide—KCNH2—Potassium Channels—ABCC9—uterine cancer	0.000248	0.0363	CbGpPWpGaD
Dofetilide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.0002	0.0293	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—ABCC9—uterine cancer	0.000108	0.0159	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—YWHAE—uterine cancer	9.04e-05	0.0133	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	8.38e-05	0.0123	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—ESR2—uterine cancer	8.34e-05	0.0122	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—HRAS—uterine cancer	6.3e-05	0.00924	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—HRAS—uterine cancer	4.83e-05	0.00708	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	4.65e-05	0.00681	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	4.58e-05	0.00672	CbGpPWpGaD
Dofetilide—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	4.23e-05	0.0062	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	3.77e-05	0.00552	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	3.55e-05	0.0052	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CXCL8—uterine cancer	3.52e-05	0.00517	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	3.42e-05	0.00501	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	3.37e-05	0.00495	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	3.3e-05	0.00484	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	3.25e-05	0.00477	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—HRAS—uterine cancer	3.07e-05	0.0045	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—EP300—uterine cancer	3.02e-05	0.00443	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—VEGFA—uterine cancer	2.86e-05	0.0042	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.77e-05	0.00406	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	2.42e-05	0.00355	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.12e-05	0.00312	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2e-05	0.00293	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.97e-05	0.00289	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.86e-05	0.00273	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.47e-05	0.00216	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.45e-05	0.00213	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—HRAS—uterine cancer	1.3e-05	0.0019	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SRD5A2—uterine cancer	7.91e-06	0.00116	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NDUFB11—uterine cancer	7.91e-06	0.00116	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKR1B1—uterine cancer	5.72e-06	0.000839	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—STAR—uterine cancer	5.72e-06	0.000839	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—POLD1—uterine cancer	4.49e-06	0.000658	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.2e-06	0.000615	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—RRM2—uterine cancer	3.74e-06	0.000549	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—DCN—uterine cancer	3.63e-06	0.000533	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.42e-06	0.000502	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.23e-06	0.000474	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—STK11—uterine cancer	2.52e-06	0.000369	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.52e-06	0.000369	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MTHFR—uterine cancer	1.89e-06	0.000277	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PTEN—uterine cancer	1.05e-06	0.000154	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—EP300—uterine cancer	1e-06	0.000147	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CA—uterine cancer	7.42e-07	0.000109	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKT1—uterine cancer	6.06e-07	8.89e-05	CbGpPWpGaD
